A 1 LYS 16 -11.249 -11.795
A 2 GLU 13 -14.925 -14.704
A 3 GLY 18 -17.196 -17.288
A 4 TYR 21 -19.500 -19.673
A 5 LEU 29 -19.668 -20.741
A 6 VAL 21 -17.469 -17.875
A 7 ASP 10 -14.724 -14.180
A 8 LYS 7 -11.500 -10.983
A 9 ASN 1 -10.219 -9.159
A 10 THR 10 -12.317 -12.051
A 11 GLY 8 -13.581 -12.939
A 12 CYS 7 -16.672 -15.560
A 13 LYS 20 -18.898 -19.024
A 14 TYR 27 -19.860 -20.681
A 15 GLU 4 -20.461 -18.568
A 16 CYS 26 -21.349 -21.884
A 17 LEU 0 -18.335 -16.227
A 18 LYS 8 -17.771 -16.647
A 19 LEU 3 -18.375 -16.607
A 20 GLY 0 -17.158 -15.185
A 21 ASP 0 -16.260 -14.390
A 22 ASN 24 -17.231 -18.010
A 23 ASP 0 -15.521 -13.736
A 24 TYR 16 -18.182 -17.931
A 25 CYS 30 -20.496 -21.589
A 26 LEU 6 -17.938 -16.565
A 27 ARG 5 -15.521 -14.311
A 28 GLU 26 -16.953 -17.993
A 29 CYS 30 -17.822 -19.222
A 30 LYS 10 -13.605 -13.190
A 31 GLN 13 -12.896 -12.908
A 32 GLN 32 -13.172 -15.337
A 33 TYR 31 -12.504 -14.631
A 34 GLY 12 -9.254 -9.570
A 35 LYS 0 -7.883 -6.977
A 36 GLY 7 -8.262 -8.117
A 37 ALA 31 -13.663 -15.657
A 38 GLY 8 -15.505 -14.642
A 39 GLY 31 -19.514 -20.835
A 40 TYR 7 -20.350 -18.815
A 41 CYS 12 -21.850 -20.717
A 42 TYR 16 -20.459 -19.947
A 43 ALA 9 -19.961 -18.700
A 44 PHE 2 -21.058 -18.867
A 45 ALA 16 -21.681 -21.028
A 46 CYS 28 -22.242 -22.904
A 47 TRP 12 -20.707 -19.706
A 48 CYS 31 -19.199 -20.556
A 49 THR 10 -16.485 -15.739
A 50 HIS 14 -12.418 -12.600
A 51 LEU 26 -11.841 -13.469
A 52 TYR 9 -7.587 -7.749
A 53 GLU 0 -6.634 -5.871
A 54 GLN 0 -7.001 -6.196
A 55 ALA 27 -11.026 -12.863
A 56 ILE 15 -12.062 -12.400
A 57 VAL 26 -15.632 -16.825
A 58 TRP 22 -15.769 -16.486
A 59 PRO 4 -13.706 -12.590
A 60 LEU 16 -11.175 -11.730
A 61 PRO 3 -5.333 -5.064
A 62 ASN 0 -2.880 -2.549 <=B
A 63 LYS 14 -7.252 -8.028
A 64 ARG 1 -10.035 -8.996
A 65 CYS 12 -13.362 -13.205
A 66 SER 5 -10.630 -9.983

Identified 1 B-Cell epitope residues out of 66 total residues